Additionally, endothelin (ET-1), which is upregulated in patients with DM, can suppress eNOS and downregulate NO via activating the RhoA/Rho-kinase pathway (Kalani, 2008; Kamenov, 2015). This evidence concerns the gene EDN1 and diabetes mellitus.